Myeloprotective effect of short-course high-dose methylprednisolone treatment before consolidation therapy in children with acute myeloblastic leukemia

American Journal of Hematology

Volumn 80, Issue 1, 2005, Pages 1-5

  Aytaç Elmas, Selin ^a   Çetin, Mualla ^a   Tuncer, Murat ^a   Hiçsönmez, Gönül ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Acute myeloblastic leukemia; Children; Consolidation therapy; High dose methylprednisolone; Neutropenia

Indexed keywords

CD34 ANTIGEN; CYTARABINE; DAUNORUBICIN; METHYLPREDNISOLONE;

ABDOMINAL PAIN; ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; CANCER CHEMOTHERAPY; CHILD; CLINICAL ARTICLE; CONSOLIDATION THERAPY; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; DRUG EFFECT; DRUG MEGADOSE; FEMALE; FOLLOW UP; HEMATOPOIETIC STEM CELL; HOSPITALIZATION; HUMAN; HUMAN CELL; HYPERTENSION; LEUKOCYTE COUNT; MALE; MYALGIA; NEUTROPENIA; NEUTROPHIL; PRIORITY JOURNAL; SHORT COURSE THERAPY;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; FEMALE; GLUCOCORTICOIDS; HUMANS; INFANT; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; METHYLPREDNISOLONE;

EID: 24344442304     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.20277     Document Type: Article

References (22)

1. Bishop JF, Matthews JP, Young GA, et al. A randomized study of high-dose cytarabine in induction in acute myeloid leukemia Blood 1996;87:1710-1717.
2. Wells RJ, Woods WG, Lampkin BC, et al. Impact of high dose cytarabine and asparaginase intensification on childhood acute myeloid leukemia: a report from the Children's Cancer Group. J Clin Oncol 1993;11:538-545.
3. Clark SC, Kamen R. The human hematopoietic colony-stimulating factors. Science 1987;236:1229-1237.
4. Okamura J, Yokoyama M, Tsukimoto I, et al. Treatment of chemotherapy-induced neutropenia in children with subcutaneously administered recombinant human granulocyte colony-stimulating factor. Pediatr Hematol Oncol 1992;9:199-207.
5. Tuncer AM, Hiçsönmez G, Gumruk F, et al. The effect of high dose methyl prednisolone combined chemotherapy on CD34-positive cells in acute lymphoblastic leukemia. Hematol Pathol 1994;8:169-175.
6. Tuncer AM, Hiçsönmez G, Gumruk F, et al. The effect of high dose methyl prednisolone on CD34-positive bone marrow cells in children with acute myeloblastic leukemia. Turk J Pediatr 1995;37:345-349.
7. Tunç B, Oner AF, Hiçsönmez G. The effect of short-course high-dose methylprednisolone on peripheral blood CD34+ progenitor cells of children with acute leukemia during remission induction therapy. Turk J Pediatr 2002;44:1-4.
8. Cetin M, Hiçsönmez G, Tuncer AM, Kansu E, Canpinar H. The effect of short-course high-dose corticosteroid therapy on peripheral blood CD34(+) progenitor cells in children with acute leukemia. Exp Hematol 1996;24:1191-1194.
9. Hiçsönmez G, Onat N, Albayrak D, Yetgin S, Ozsoylu S. Acceleration of leukocyte recovery by administration of short-course high dose methyl prednisolone in children with acute leukemia. Pediatr Hematol Oncol 1991;8:193-195.
10. Hiçsönmez G, Cetin M, Tuncer AM, et al. Children with acute myeloblastic leukemia presenting with extramedullary infiltration: the effect of high-dose steroid treatment. Leuk Res 2004;28:25-34.
11. Motoji T, Watanabe M, Uzumaki H, et al. Granulocyte colony-stimulating factor (G-CSF) receptors on acute myeloblastic leukemia cells and their relationship with the proliferative response to G-CSF in clonogenic assay. Br J Haematol 1991;77:54-59.
12. Douer D, Koeffler HP. Retinoic acid enhances colony stimulating factor-induced clonal growth of human myeloid progenitor cells in vitro. Exp Cell Res 1982;138:193 Hiçsönmez 197.
13. Sakashita A, Kizaki M, Pakkala S, et al. 9-cis-Retinoic acid: effects on normal and leukemic hematopoiesis in vitro. Blood 1993;81:1009-1016.
14. Visani G, Tosi P, Cenacchi A, et al. Pre-treatment with all-trans-retinoic acid accelerates polymorphonuclear recovery after chemotherapy in patients with acute promyelocytic leukemia. Leuk Lymphoma 1994;15:143-147.
15. Hiçsönmez G, Tuncer M, Toksoy HB, Yenicesu I, Cetin M. Differentiation of leukemic cells induced by short-course high-dose methylprednisolone in children with different subtypes of acute myeloblastic leukemia. Leuk Lymphoma 1999;33(5-6):573-580.
16. Hiçsönmez G, Cetin M, Okur H, Erdemli E, Gurgey A. The potential effect of short-course high-dose steroid on the maturation and apoptosis of leukemic cells in a child with acute megakaryoblastic leukemia. Leuk Lymphoma 2003;44;1037-1042.
17. Hiçsönmez G. A novel approach to treatment with high-dose steroid as a differentiation inducer in children with acute myeloblastic leukemia. Pediatr Pathol Mol Med 2000;19:251-259.
18. Krystosek A, Sachs L. Steroid hormone receptors and the differentiation of myeloid leukemic cells. J Cell Physiol 1977;95:345-352.
19. Tuncer AM, Hiçsönmez G, Gumruk F, et al. Serum TNF-alpha, gamma-INF, G-CSF and GM-CSF levels in neutropenic children with acute leukemia treated with short-course, high-dose methylprednisolone. Leuk Res 1996;20:265-269.
20. Olofsson T, Sallerfors B. Modulation of the production of leukemia associated inhibitor (LAI) and its interaction with granulocyte macrophage colony-forming cells. Exp Haematol 1987;15:1163-1167.
21. Kriegler AB, Bernardo D, Verschoor SM. Protection of murine bone marrow by dexamethasone during cytotoxic chemotherapy. Blood 1994;83:65-71.
22. Wang H, Ci M, Rinehart JJ, Zhang R. Dexamethasone as a chemoprotectant in cancer chemotherapy: hematoprotective effects and altered pharmacokinetics and tissue distribution of carboplatin and gemcitabine. Cancer Chemother Pharmacol 2004;53:459-467.